Diabetes Education With Real-time Continuous Glucose Monitoring
NCT ID: NCT05394844
Last Updated: 2025-12-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2022-11-11
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Glucose Monitoring in Diabetes and Prediabetes
NCT03805412
Community Glucose Monitoring Project
NCT05351190
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
NCT03620357
Dexcom G6 Intervention Study
NCT03877068
Steno2tech - Continuous Glucose Monitoring and Type 2 Diabetes.
NCT04331444
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CGM with DM education
if you are in the intervention group you will received culturally tailored diabetes education and use a Real Time CGM device to see your glucose over 12 weeks. Both group will completed blinded CGM at the beginning of the study and at 24 weeks
Dexcom G6
Dexcom G6 CGM device
Education only
If you are in the control group your will receive culturally tailored diabetes education and wear a blinded prior to education and after education sessions complete and 24 weeks
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexcom G6
Dexcom G6 CGM device
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Self-identify as Latinx
3. Have had a clinical diagnosis of T2D within the last 15 years with or without medication use
4. Have an A1C ≥8.0% at screening
5. Own or have routine access to a personal device that allows attending educational sessions virtually
6. Be physically and cognitively able to use the home CGM monitoring device
7. Be willing and able to follow all other study procedures
Exclusion Criteria
2. Type 1 diabetes or latent autoimmune diabetes
3. Current use of prandial insulin
4. Any condition that prevents walking at least 1 city block
5. History of serious mental illness other than adequately treated depression
6. History of bariatric surgery or current participation in a weight management program
7. Current diagnosis of cancer or other serious or systemic medical condition
8. Significant active cardio- or cerebrovascular disease after review by PI
9. Pregnancy
10. know history x of of hypoglycemia unawareness
11. Unable to read, understand, and sign the Informed Consent Form (ICF) and if applicable, an Authorization to Use and Disclose Protected Health Information form (consistent with Health Insurance Portability and Accountability Act of 1996 \[HIPAA\] legislation), communicate with the investigator, and understand and comply with protocol requirements
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Diabetes Association
OTHER
Washington State University
OTHER
Sea Mar Community Health Centers
OTHER
DexCom, Inc.
INDUSTRY
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicole Ehrhardt
Assistant Professor of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Washington Diabetes Institute
Seattle, Washington, United States
University of Washington
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ehrhardt N, Cedeno B, Montour L, Sinclair K, Ferguson G, Berberian P, Comstock B, Wright L. Effectiveness of a culturally tailored diabetes education curriculum with real-time continuous glucose monitoring in a Latinx population with type 2 diabetes: the CUT-DM with CGM for Latinx randomised controlled trial study protocol. BMJ Open. 2023 Dec 28;13(12):e082005. doi: 10.1136/bmjopen-2023-082005.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00014396
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.